This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Hold Strategy is Apt for AmEx (AXP) Stock Now
by Zacks Equity Research
American Express (AXP) is expected to keep growing from its expanding footprint in the global market and capturing the younger demographic.
Marsh & McLennan (MMC) Unit Buys Digital HR Firm Leapgen
by Zacks Equity Research
The Leapgen buyout is expected to enable Marsh & McLennan's (MMC) business, Mercer, to provide better HR digital solutions that can improve return on investment and utilization.
Ares Capital (ARCC) Stock Moves -0.05%: What You Should Know
by Zacks Equity Research
Ares Capital (ARCC) closed at $19.35 in the latest trading session, marking a -0.05% move from the prior day.
Zacks Industry Outlook Highlights Ares Capital, Main Street Capital and Hercules Capital
by Zacks Equity Research
Ares Capital, Main Street Capital and Hercules Capital have been highlighted in this Industry Outlook article.
Are Finance Stocks Lagging Apollo Commercial Real Estate Finance (ARI) This Year?
by Zacks Equity Research
Here is how Apollo Commerical Finance (ARI) and Ares Capital (ARCC) have performed compared to their sector so far this year.
3 Stocks From Flourishing SBIC & Commercial Finance Industry
by Swayta Shah
Higher rates, decent economic growth, robust asset quality and regulatory changes are likely to keep aiding the Zacks SBIC & Commercial Finance industry players like Ares Capital (ARCC), Main Street Capital (MAIN) and Hercules Capital (HTGC).
Wall Street Analysts Think Ares Capital (ARCC) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Ares Capital (ARCC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
New Strong Buy Stocks for February 10th
by Zacks Equity Research
SNEX, DTEGY, CLVT, HAE and ARCC have been added to the Zacks Rank #1 (Strong Buy) List on February 10, 2022.
Ares Capital (ARCC) Gains 2.2% as Q4 Earnings Beat Estimates
by Zacks Equity Research
Higher total investment income and decline in expenses support Ares Capital's (ARCC) Q4 earnings.
Here's What Key Metrics Tell Us About Ares Capital (ARCC) Q4 Earnings
by Zacks Equity Research
The headline numbers for Ares Capital (ARCC) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ares Capital (ARCC) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Ares Capital (ARCC) delivered earnings and revenue surprises of 21.43% and 10.78%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Ares Capital (ARCC) This Earnings Season?
by Zacks Equity Research
Ares Capital (ARCC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Rithm Capital (RITM) to Post Q4 Earnings: What to Expect
by Zacks Equity Research
Rithm Capital's (RITM) fourth-quarter results are likely to reflect a significant decrease in net servicing revenues.
AON Q4 Earnings Beat on Strong Reinsurance & Health Solutions
by Zacks Equity Research
AON expects to achieve double-digit free cash flow growth in 2023 and the long run.
Will CME Group (CME) Keep Its Beat Streak Alive in Q4 Earnings?
by Zacks Equity Research
CME Group's (CME) Q4 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services. However, higher expenses might have been an offset.
Ares Capital (ARCC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Ares Capital (ARCC) closed at $19.78, marking a +0.51% move from the previous day.
Aflac (AFL) Q4 Earnings Beat on Lower Benefits and Expenses
by Zacks Equity Research
Aflac (AFL) hikes dividends to 42 cents per share for the first quarter of 2023, marking a 5% increase.
MetLife (MET) Q4 Earnings Miss on Lower Investment Income
by Zacks Equity Research
MetLife (MET) expects pre-tax variable investment income of $2 billion for 2023.
Ares Capital (ARCC) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Ares Capital (ARCC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Ares Capital (ARCC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Ares Capital (ARCC) closed at $19.68, marking a +1.6% move from the previous day.
Virtu Financial (VIRT) Declines 5.8% Since Q4 Earnings Miss
by Zacks Equity Research
Virtu Financial (VIRT) has $311.9 million remaining under its share buyback authorization for future purchases.
Can AON's Q4 Earnings Beat on Commercial Risk Performance?
by Zacks Equity Research
AON's fourth-quarter results are likely to reflect the fruits of business generation and robust retention.
Ares Capital (ARCC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ares Capital (ARCC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
American Express (AXP) Misses on Q4 Earnings, Gives Upbeat View
by Zacks Equity Research
American Express (AXP) intends to hike dividends by 15% to 60 cents per share, starting from the first quarter of 2023.
Ares Capital (ARCC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Ares Capital (ARCC) closed the most recent trading day at $19.62, moving +1.29% from the previous trading session.